PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
Open Access
- 21 July 2005
- journal article
- other
- Published by Springer Nature in Leukemia
- Vol. 19 (9) , 1692-1696
- https://doi.org/10.1038/sj.leu.2403879
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion geneOncogene, 2005
- The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2Cancer Research, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human LeukemiaScience, 1997
- Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid LeukemiaBlood, 1997